Eldelumab
Product Specifications
CAS Number
946414-98-8
Target
CXCR
Related Pathways
Immunology/Inflammation|||GPCR/G Protein|||Autophagy
Purity
0.973
Bioactivity
Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416316517253311/T76741
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1436401-01 0.02 mg (E-Coli)
Recombinant Bombyx mori Eukaryotic translation initiation factor 3 subunit G (eIF3-S4)
Ask
View Details 
MBS1436401-02 0.02 mg (Yeast)
Recombinant Bombyx mori Eukaryotic translation initiation factor 3 subunit G (eIF3-S4)
Ask
View Details 
MBS1436401-03 0.1 mg (E-Coli)
Recombinant Bombyx mori Eukaryotic translation initiation factor 3 subunit G (eIF3-S4)
Ask
View Details MBS1436401-04 0.1 mg (Yeast)
Recombinant Bombyx mori Eukaryotic translation initiation factor 3 subunit G (eIF3-S4)
Ask
View Details